Dana Pizzuti - Net Worth and Insider Trading
Dana Pizzuti Net Worth
The estimated net worth of Dana Pizzuti is at least $2 Million dollars as of 2024-11-05. Dana Pizzuti is the Chief Med and Dev Officer of Crinetics Pharmaceuticals Inc and owns about 28,507 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $2 Million. Details can be seen in Dana Pizzuti's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dana Pizzuti has not made any transactions after 2024-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dana Pizzuti
Dana Pizzuti Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dana Pizzuti owns 1 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) .
Click here to see the complete history of Dana Pizzuti’s form 4 insider trades.
Insider Ownership Summary of Dana Pizzuti
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | 2024-10-03 | Chief Development Officer |
Dana Pizzuti Latest Holdings Summary
Dana Pizzuti currently owns a total of 1 stock. Dana Pizzuti owns 28,507 shares of Crinetics Pharmaceuticals Inc (CRNX) as of October 3, 2024, with a value of $2 Million.
Latest Holdings of Dana Pizzuti
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | 2024-10-03 | 28,507 | 57.02 | 1,625,469 |
Holding Weightings of Dana Pizzuti
Dana Pizzuti Form 4 Trading Tracker
According to the SEC Form 4 filings, Dana Pizzuti has made a total of 8 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 14,375 shares on October 3, 2024, which brought Dana Pizzuti around $785,306.
Insider Trading History of Dana Pizzuti
- 1
Dana Pizzuti Trading Performance
Dana Pizzuti Ownership Network
Ownership Network List of Dana Pizzuti
Ownership Network Relation of Dana Pizzuti
Dana Pizzuti Owned Company Details
What does Crinetics Pharmaceuticals Inc do?
Who are the key executives at Crinetics Pharmaceuticals Inc?
Dana Pizzuti is the Chief Development Officer of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include See Remarks Marc Wilson , Chief Scientific Officer Stephen F. Betz , and Chief Operating Officer Jeff E. Knight .
Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary
Over the past 18 months, Dana Pizzuti made 7 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 91,672. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 40,035 shares made by Stephen F. Betz , a net sale of 159,049 shares made by Marc Wilson , and a net sale of 448,399 shares made by Richard Scott Struthers .
In summary, during the past 3 months, insiders sold 46,410 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 46,410 shares. During the past 18 months, 913,970 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 908,970 shares.
Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crinetics Pharmaceuticals Inc Insider Transactions
Dana Pizzuti Mailing Address
Above is the net worth, insider trading, and ownership report for Dana Pizzuti. You might contact Dana Pizzuti via mailing address: C/o Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Building 2, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
